These data suggest that whereas regulatory components of the alternative pathway are not differentially expressed in human NASH, neutrophils surrounding steatotic hepatocytes may still serve as an important source of properdin. The gene discussed is CFP; the disease is metabolic dysfunction-associated steatohepatitis.